PTGS2 and atopic eczema: In our present study, TECA treatment inhibited activation of NF-κB contributing to the reduced pro-inflammatory cytokine and expression of iNOS and COX-2 in PA-induced allergic dermatitis animal model as well as RAW 264.7 murine macrophage.